Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in LLY — ELI LILLY & Co

CIK 72971 SAN FRANCISCO, CA
Back to LLY Full portfolio

Position in LLY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,572,694,974
+$1,520,331,841 QoQ
Shares Held
4,646,119
+5.5% QoQ
Ownership
0.494%
of shares outstanding
% of Portfolio
1.52%
of 13F equity value
Holder Rank
#30
of 4,632 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 90% Shared 0% None 10%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Derivatives in LLY

reported options exposure · as of Jun 30, 2026
CallValue
$14,992,876
CallShares
12,500
PutValue
$694,829,856
PutShares
579,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $19,103,501,096 across 19 Drug Manufacturers - General names. LLY ranks #1 (29.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
This page 		4,646,119 $5,572,694,974
2 JNJ
Johnson & Johnson
 17,374,433 $4,412,584,747
3 AMGN
Amgen Inc
 7,235,462 $2,620,105,497
4 ABBV
AbbVie Inc.
 9,017,580 $2,269,183,828
5 MRK
Merck & Co., Inc.
 11,658,434 $1,498,108,767
6 GILD
Gilead Sciences, Inc.
 6,439,586 $813,577,293
7 PFE
Pfizer Inc
 20,193,675 $486,263,691
8 BMY
Bristol Myers Squibb Co
 6,321,643 $364,253,067

All Filings in LLY

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,992,876 12,500
2026-06-30 $694,829,856 579,300
2026-06-30 $5,572,694,974 4,646,119
2026-03-31 $4,052,363,133 4,405,844
2026-03-31 $3,679,080 4,000
2026-03-31 $471,566,079 512,700
2025-12-31 $4,656,218,106 4,332,655
2025-12-31 $557,544,035 518,800
2025-09-30 $2,459,473,275 3,223,425
2025-09-30 $498,773,100 653,700
2025-09-30 $11,445,000 15,000
2025-06-30 $353,984,573 454,100
2025-06-30 $2,431,601,178 3,119,317
2025-03-31 $401,474,851 486,100
2025-03-31 $142,304,293 172,300
2025-03-31 $2,449,491,308 2,965,809
2024-12-31 $11,734,400 15,200
2024-12-31 $2,282,574,716 2,956,703
2024-12-31 $411,630,400 533,200
2024-09-30 $2,607,807,799 2,943,549
2024-09-30 $40,044,488 45,200
2024-09-30 $393,445,954 444,100
2024-06-30 $2,686,752,267 2,967,541
2024-06-30 $303,392,838 335,100
2024-03-31 $2,272,187,770 2,920,700
2024-03-31 $228,486,852 293,700
2023-12-31 $466,336 800
2023-12-31 $82,133,428 140,900
2023-12-31 $1,776,641,061 3,047,830
2023-09-30 $4,673,031 8,700
2023-09-30 $1,565,804,311 2,915,131
2023-09-30 $429,704 800
2023-06-30 $1,431,818,917 3,053,049
2023-06-30 $375,184 800
2023-06-30 $5,346,372 11,400
2023-03-31 $1,339,338 3,900
2023-03-31 $2,678,676 7,800
2023-03-31 $1,030,423,122 3,000,475
2022-12-31 $219,504 600
2022-12-31 $329,256 900
2022-12-31 $1,104,650,585 3,019,491
2022-09-30 $6,467,000 20,000
2022-09-30 $979,659,314 3,029,718
2022-09-30 $3,233,500 10,000
2022-06-30 $1,036,851,873 3,197,890
2022-03-31 $933,319,347 3,259,138
2021-12-31 $5,524,400 20,000
2021-12-31 $866,637,209 3,137,489
2021-09-30 $757,568,585 3,278,808
2021-06-30 $777,374,137 3,386,956